NCT00483860 - A Phase I Topotecan Study in Subjects With Cancer and Impaired Renal Function | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 20, 2007

Primary Completion Date

February 6, 2012

Study Completion Date

February 6, 2012

Conditions

Solid Tumours

Interventions

DRUG

Topotecan

once a day

Trial Locations (6)

GSK Investigational Site, Scottsdale

GSK Investigational Site, Lebanon

GSK Investigational Site, Amsterdam

GSK Investigational Site, Utrecht

GSK Investigational Site, Seoul

GSK Investigational Site, Seoul